종목/ELV
Elevance Health, Inc.
FY 2026 diluted EPS: At least $19.85 (including the Company's estimate of the financial impact for the CMS matter)
FY 2026 adjusted diluted EPS: At least $26.75
Reaffirm FY 2026 operating cash flow: At least $5.5 billion
아래 내용은 AI 가 8-K Item 2.02 본문과 보도자료(Exhibit 99.x)를 종합해 한국어로 정리한 요약입니다. 핵심 하이라이트·가이던스·운영 코멘트·시장 평가 네 섹션 모두 AI 생성이며, 실제 원문은 EDGAR 링크에서 확인하세요.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
| 발표일 | 분기 | EPS 예상 | EPS 실제 | Surprise | 매출 실제 | 발표 직후 반응 |
|---|---|---|---|---|---|---|
| 4월 22일 (수) | 2026 Q1 | $10.93 | $12.58 | +15.1% | $49.49B | — |
| 12월 1일 (월) | 2025 Q4 | $3.09 | $3.33 | +7.7% | $50.71B | — |
| UNH | 유나이티드헬스 | 345B | +8.9% | 75% (3/4) |
| MRK | 머크 | 275B | +16.0% | 100% (4/4) |
조정 기준(Adjusted EPS)과 상향된 가이던스로 단기적으로는 긍정적(beat·상향 신호)으로 해석될 가능성이 크다. 다만 CMS 관련 대규모 계상액과 일부 핵심 회원군(특히 Medicare Advantage, Employer Group risk)의 축소, 운영비율 상승은 리스크로 작용할 수 있어 투자자들은 CMS 사안 전개와 의료비 추세를 주시할 전망이다.
| 9월 1일 (월) | 2025 Q3 | $4.94 | $6.03 | +22.0% | $49.78B | — |
| 6월 1일 (일) | 2025 Q2 | $8.96 | $8.84 | −1.4% | $48.89B | — |